Dr M Ayyappan, chairman and managing director, HLL Lifecare
Dr M Ayyappan, who transformed HLL Lifecare into a global healthcare company with its portfolios ranging from a leading manufacturer of quality contraceptives to interventions in public health programmes during the last one decade, has been given another extension as its chairman and managing director by the government of India.
Dr Ayyappan, who began his stint with HLL in 1991 as marketing manager, and later became its managing director in 2003. Two years later, in 2005, he rose to the pinnacle of its management hierarchy by becoming the CMD of the mini-ratna public sector undertaking under the Union Ministry of Health and Family Welfare.
Under the stewardship of Dr Ayyappan, HLL Lifecare (formerly known as Hindustan Latex), a condom-manufacturer in the country, has become a healthcare behemoth and the sole PSU of its kind that has successfully forayed into areas like infrastructure development, consultancy, healthcare products, medical devices, healthcare treatment, blood bags, diagnostic services and vaccines.
"My mandate will be to continue the social interventions that HLL is making and make sure that the healthcare delivery system in our country becomes affordable to the underserved population," Dr Ayyappan said, reacting to his extension.
Under his leadership, HLL got upgraded to a schedule B and mini-ratna company, clocking rapid growth since 2003-04 and doing business worth Rs 1,131 crore in 2012-13-a growth of 35 percent in its turnover and profitability as compared to the previous year.